The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K

Mikołaj Słabicki(Broad Institute), Zuzanna Kozicka(University of Basel), Georg Petzold(Friedrich Miescher Institute), Yen-Der Li(Broad Institute), Manisha Manojkumar(Broad Institute), R.D. Bunker(Friedrich Miescher Institute), Katherine A. Donovan(Harvard University), Quinlan Sievers(Broad Institute), Jonas Koeppel(Broad Institute), Dakota J. Suchyta(University of Basel), Adam S. Sperling(Broad Institute), Emma C. Fink(Broad Institute), Jessica A. Gasser(Broad Institute), Li R. Wang(Broad Institute), Steven M. Corsello(Broad Institute), Rob S. Sellar(Broad Institute), Max Jan(Broad Institute), Dennis Gillingham(University of Basel), Claudia Scholl(German Cancer Research Center), Stefan Fröhling(German Cancer Research Center), Todd R. Golub(Broad Institute), Eric S. Fischer(Harvard University), Nicolas H. Thomä(Friedrich Miescher Institute), Benjamin L. Ebert(Broad Institute)
Nature
June 3, 2020
Cited by 406Open Access
Full Text

Abstract


Related Papers

No related papers found

Powered by citation graph analysis